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Abstract
The murine alveolar macrophage cell line, MH-S, constitutively expresses the
immunoregulatory antigenCD40. Previous experiments have demonstrated thatCD40
expression is upregulated following infection with the DNA virus, mouse adenovirus 1
(MAV-1), suggesting a role forCD40 in MAV-1 infection. The purpose of this experiment is
to investigate the effect ofCD40 silencing on MAV-1 replication in MH-S cells. To elucidate
the importance ofCD40 signaling in MAV-1 replication,CD40 expression was reduced
using a short hairpin RNA (shRNA) RNAi system. FiveCD40-silenced lines were generated
using shRNA and showed between 26-79 percent reduction in cell surfaceCD40 expression
from wild type. To assess the effect of MAV-1 infection on costimulatory markers,CD40
expression was compared between the silenced cell line that showed the greatest level of
CD40 suppression (designated NPBS) and wild type cells at I-day post infection. Flow
cytometry revealedCD40 expression was increased in both cell lines following infection
with MAV-1. InfectedCD40-silenced cultures expressed approximately 50% the level of
CD40 as infected wild type cultures. Further characterization ofCD40-deficient MH-S cells
may reveal novel mechanisms through which MAV-1 infection alters host cell metabolism.
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Introduction
Adenoviruses
Adenoviruses are icosahedral, double-stranded DNA viruses that infect a wide range
of vertebrate hosts (Zhao et al., 2014). Adenovirus infection of humans predominantly affects
adolescents and causes a wide range of upper and lower respiratory diseases (Carbal et al.,
2002). Most cases of adenovirus infection are acute (10-14 days), however persistent
infections are commonly observed in immunocompromised patients (Chakrabarti et al., 2002;
Ghebremedhin, 2014). Adenovirus infection of immunocompromised patients tends to cause
more severe infections than observed in immunocompetent patients. Studies have shown that
5-21% of patients are infected with adenovirus following stem cell transplantation and the
mortality rate in this patient population is as high as 50% (Chakrabarti et al., 2002). A better
understanding of how adenoviruses cause disease may allow for the development of new
treatments and decrease the mortality rate in immunocompromised patients.

Mouse Adenovirus - 1
Human adenoviruses (hAd) are species specific and are therefore difficult to
experimentally study outside their host (Wadell, 1984). Due to similarities between mouse
adenovirus I (MAV-1) and human adenoviruses, and the availability of susceptible inbred
mice, MAV-1 is an ideal model to study adenoviral infection. MAV-1 and human
adenoviruses share a substantial amount of genomic and structural homology (Wigand et al.,
1997). For example, MAV-1 and human adenoviruses share approximately 40% sequence
similarity between the adenovirus early region IA {El A) genes, with increased sequence
similarity in the conserved region 2 (CR2) (Ball et al., 1988; Elliot et al., 1995). MAV-1
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E1A shares similar functions with hAd EI A, such as binding to host retinoblastoma (Rb)
proteins (Fang et al., 2003).
MAV-1 primarily targets endothelial cells throughout the mouse and produces the
highest level of virus in the brain, spinal cord and spleen (Lenarts et al., 2009). Most studies
on adenovirus infection have been conducted on endothelial cells, however cells of the
monocyte lineage also are targeted during infection during MAV-1 infection (Ashley et al.,
2009). MAV-1 infection causes pneumonia, hepatitis, encephalitis, gastroenteritis, and
disseminated disease involving multiple organs in immunocompromised mice (Ashley et al.,
2009). Different strains of inbred mice show varying levels of susceptibility to MAV-1.
C57BL/6 mice succumb to fatal hemorrhagic encephalomyelitis (inflammation of the brain)
when infected with MAV-1, while BALB/c mice do not (Guida et al., 1995). 40% of the
susceptibility trait for MAV-1 infection is controlled by a locus on chromosome 15
containing over 250 identified genes (Welton et al., 2005). It is unclear which genes are
responsible for MAV-1 susceptibility. These experiments suggest that there is strong
correlation between host allelic variation and susceptibility to MAV-1.
Expression of adenoviral genes is modulated throughout the course of infection.
Depending on the stage of infection, adenoviruses produce either predominantly early or late
gene products (Figure 1). Early gene products generally promote viral replication and
stimulate the transcription of late gene products, while most late gene products are structural
proteins, such as the hexamer capsid component (Waye and Sing, 2010).
Early adenovirus gene products include El A, ElB, E2, E3 and E4 (Fessler and
Young, 1998). Early region IA (EIA) and early region l B (EIB) gene products alter the cell
cycle of infected hosts (McCormick, 2001). The E l A and ElB genes each encode proteins
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that promote the transcription of other early gene products. These early gene products
interfere with host cell cycle mechanisms by reducing the functionality of the tumor
suppressors retinoblastoma protein (Rb) and tumor protein 53 (p53) (Figure 2) (McCormick,
2001). This experiment examines how MAV-1 replication alters host cell metabolism. It is
possible that early genes also alter other physiological aspects of their hosts. These
alterations may promote viral replication, especially if they can alter immune effectors, such
as macrophages.

Figure l . Summary of Adenovirus Infection. (Image from Waye and Sing, 2010)
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Figure 2. Model of Cell Cycle Manipulation by EIA and ElB. (Image from McCormick,
2001)

Immunological Significance ofMacrophages
Macrophages can be found in all tissues as resident populations and can be recruited
to other tissues following pathogen invasion or tissue injury (Kennedy and Abkowitz, 1998).
Mature macrophages contribute to tissue homeostasis and aid in pathogen clearance through
their functions in the innate and adaptive immune system. The main effector functions of
macrophages are antigen presentation, phagocytosis of debris and pathogens, and
immunomodulation (Stout & Suttles, 2004). Monocytes are derived from myeloid precursors
in the bone marrow, spleen and liver (Stout & Suttles, 2004). Monocytes circulate through
the blood and can be induced to differentiate into macrophages by exposure to numerous
biological factors such as cytokines, chemokines, hormones and immunoglobulins (Stout &
Suttles, 2004; Dale et al., 2008).
Macrophages that reside within the alveolar sacs of the lungs are known as alveolar
macrophages. Alveolar macrophages serve as the first line of defense against respiratory
pathogens through various immunological mechanisms such as phagocytosis, and the
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secretion of lysozyme, antimicrobial peptides and proteases (Sibelle et al., 2003). When
macrophages are infected by pathogens, these innate and adaptive immune functions can
become impaired, leading to the progression of opportunistic infections (Sibelle et al., 2003).
MAV-1 infection of macrophages has not been as well studied as other cell types.
MH-S cells (used in this study) are derived from alveolar macrophages from BALB/c
mice. Given that BALB/c mice are more resistant to MAV-1 infection than

C57BU6 mice, it

is possible that BALB/c mice contain immunological attributes that prevent persistent MAV
I infections. One possible explanation why BALB/c are more resistant to MAV-1 infection is
that they contain alleles that make their macrophages more efficient in recognizing
adenoviral infection and promoting a Tm response. Studies have shown that dendritic cells
infected with human adenovirus promote the generation of Tm cells (Rea et al., 1999).
Dendritic cells and macrophages are both antigen presenting cells, so it is likely that
macrophages may be inducing a similar response to MAV-1 infection. Tm responses prepare
the immune system to respond to intracellular infections, like viruses, through the secretion
of cytokines such as IFN-y, IL-2, and TNF- P (Romagnani, 1992).
One assumption made during this study is that MH-S cells are representative of
alveolar macrophages from BALB/c mice. Due to the finite lifespan of macrophages, MH-S
cells were immortalized using simian virus 40 (SV-40), inducing the expression of SV-40
large T antigen (Mbawuike and Herscowitz, 1989). SV-40 large T antigen has many of the
properties of ElB, such as binding to p53 and inhibiting its function (Xing et al., 2001).
During adenovirus infection ElB protects the virus from p-53 induced antiviral responses,
such as apoptosis, which can be induced by E l A (White, 1995). The expression of T antigen
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in MH-S cells creates unique limitations in studying adenoviral infection in MH-S cells due
to the overlap in functions between E l B and large T antigen.
Nonetheless, MH-S cells are still a valuable model to study pathogenic infection in
vitro due to the fact that this cell line maintains many of the functional characteristics of
macrophages, such as being esterase positive, peroxidase negative, and expressing the cell
surface antigens la and Mac-I (Mbawuike and Herscowitz, 1989). Previous studies have
used MH-S cells as an effective model for Legionella pneumophila infection of alveolar
macrophages (Matsunaga et al., 200 I).
MAV-1 infection of monocytes is unique in that monocytes serve as both the target
cells for infection and the effector cells that mediate the immune response against the virus
(Ashley et al., 2009). Infection of cells of the monocyte lineage could have profound effect
on the host immune system through the depletion of effector immune cells. In addition,
depletion of monocytes would reduce the number of antigen presenting cells able to stimulate
helper T cells and activate the adaptive immune system (Luster, 2002).

CD40
CD40 is a cell surface receptor protein found on B lymphocytes, dendritic cells,
follicular dendritic cells, hematopoietic progenitor cells, certain epithelial cells, carcinomas
and macrophages (Banchereau et al., 1994 ). CD40 is a costimulatory antigen belonging to the
tumor necrosis family receptor (TNFR) family (Elgueta et al., 2009). Macrophage activation
and effector cell functions are, in part, regulated through cellular signaling pathways initiated
by CD40 ligation (Stout and Suttles, 2004). CD40 ligand (CD40L) is expressed on activated
T-cells and promotes the activation of macrophages (Elgueta et al., 2009). L igation is the
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process through which ligands bind to their respective receptors to initiate cellular signaling
pathways.
L igation between CD40 and CD40 ligands promotes clustering of CD40 in
sphingolipid-rich domains of the plasma membrane and recruits TNFR associated factors
(TRAF) proteins to the cytoplasmic domain of CD40 (Stout and Suttles, 2004). TRAF
proteins initiate a variety of complex cellular signaling pathways leading to the regulation of
nuclear factor KB (NFKB), mitogen activated protein kinases (MAPKs) and phospholipase Cy

(PLCy) signaling pathways (Bishop et al, 2007). Figure 3 summarizes the major functions of
CD40 signaling. These pathways alter gene expression to promote a proinflammatory
response (Bishop et al, 2007). TRAF proteins are also used by other receptors involved in the
immunological activation. For example, TRAFs 2 and 6 are recognized as direct signal
transducers for TNF receptors and initiate signaling pathways that promote an antiviral
response (Yang et al., 2005).
Ligation of CD40 on macrophages induces the production of numerous cytokines,
such as IL-Ip, TNF-a, IL-6 and IL-8 (Companjen et al., 2002). These cytokines help to
recruit and activate other mediators of the immune system. However, sometimes these
cytokines can have counterproductive effects when viruses exploit these cytokines to
promote their own pathogenesis. For example, expression ofTNF-a causes increased
transcription of human adenovirus early region 3 (E3) (Komer et al., 1992). Thus, CD40
signaling could potentially increase the expression of transcription factors that promote viral
replication.
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Figure 3. CD40 Signaling Pathways. (Image from Elgueta et al., 2009)

Ongoing research in Michael Angeli's laboratory suggests that CD40 surface
expression is upregulated in murine alveolar macrophage (MH-S) cells as early as 9 hours
after infection with MAV-1. Previous research has shown that CD40 surface expression is
not upregulated following infection with UV irradiated virus (data not published). These
experiments are consistent with the hypothesis that CD40 upregulation is the result of viral
mRNA pathogen associated molecular patterns (PAMPs) recognized by pattern recognition
receptors (PRR) in MH-S cells. RIG-I is a PRR that aids in the activation of the innate
antiviral immune system through the detection of viral mRNA in the cytoplasm through the
initiation of signaling pathways that result in the production of type-I interferons (Xiaomo et
al., 2012). A summary of RIG-I detection of viral mRNA is shown below in figure 4.
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Figure 4. Detection of Viral mRNA by RIG-I. (Image from: Jiang et al., 2012)

This hypothesis is consistent with studies showing that RIG-I deficient mice succumb
to fatal MAV-1 infection in vivo within 7 days of infection (Vaysburd et al., 2013). These
observations suggest that recognition of viral PAMPS is required for efficient immunological
function. UV irradiation of the virus inactivates the virus and blocks successful infection.
Thus, it appears that adenovirus needs to be actively replicating to promoteCD40
upregulation.
MAV-1 recognition by PRRs may be activating signaling cascades that upregulate the
expression of CD40. This study focuses on MH-S cells and the upregulation ofCD40
observed following MAV-1 infection is most likely involved in activating macrophages to
promote their effector functions. Other targets of MAV-1 infection also possess CD40, such
as endothelial cells. Studies have shown that CD40 expression is increased in human
endothelial cells infected with human cytomegalovirus between 8 and 72 hours post infection
(Maisch et al., 2002).
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Endothelial cells are the primary targets of MAV-1 infection, while macrophages are
a secondary target {Banchereau et al., 1994; Kotowicz et al., 2000). CD40 expression on
endothelial cells is heavily influenced by cytokines, and is suggested to be involved in the
development of T-cell inflammatory reactions {Karmann et al., 1995). It is unknown whether
MAV-1 infection of endothelial cells induces the same upregulation of CD40 seen in MH-S
cells. If CD40 upregulation is the result of PRR signaling, endothelial cells may also
upregulate CD40 in response to MAV-1 infection through extracellular and intracellular

PRRs {Opitz et al, 2007).
CD40 upregulation may be the result of macrophage activation in response to MAV-1
infection. Studying the role of CD40 upregulation in vitro is difficult, due to the absence of
other immune effectors that may interact with CD40 in vivo. The goals of this study are to
develop CD40 silenced cell lines and determine if CD40 silencing impacts MAV-1 infection,
in the absence of any stimulation from other immune cell types. However, the true function
of CD40 upregulation may be obscured due to the absence of certain costimulatory signals
from other cell types that will not be present.

RNA Interference
There are numerous methods that silence the expression of specific genes such as
siRNA, RNAi, TALEN and CRISPR {Booettcher & McManus, 2015). This study uses RNA
interference {RNAi) to silence the expression of CD40. RNAi can be used to silence the
expression of specific genes through the generation of double-stranded RNA (dsRNA),
which leads to degradation of corresponding mRNA transcripts (Rao et al., 2009).
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Lentiviral vectors provide a fast and efficient means of modulating gene expression in
mammalian cells using RNAi (Shearer & Saunders, 2015). Lentiviral mediated RNAi is an
attractive option for silencing because the integration of CD40 silencing shRNA into the
DNA of the target cell enables constitutive expression of the silencing construct (Rao et al.,
2009).
Transcription of shRNA ultimately silences the expression of specific mRNA
transcripts based on sequence complementarity. A summary of lentiviral mediated shRNA
silencing is shown in figure 5. The lentivirus attaches to the host cell and injects ssRNA
containing the shRNA construct. The ssRNA is reverse transcribed to DNA, which can then
be integrated into the genome of the target cell. Following the integration of the shRNA
sequence, it is expressed by the host cell and cleaved by the enzyme dicer to produce siRNA.
siRNA is then able to bind to complementary mRNA transcripts and target them for
degradation, thus inhibiting protein expression.
The shRNA transcript used in this study has successfully been used to silence the
expression of CD40 in murine bone marrow derived monocytes (Kalantri et al., 2013). The
silencing construct contains CD40 shRNA, and a puromycin resistance gene to select for
cells expressing the construct. Constitutive expression is provided through the human U6
promoter. U6 is a member of uridine rich small nuclear RNAs (snRNA) (Almada et al.,
2013). Other experiments have successfully silenced CD40 expression using similar gene
silencing techniques (Hueso et al, 2016; Kawabe et al., 1994).
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Figure 5. Summary ofLentiviral mediated RNAi. (Image from Liszewski, 201 1 }

Materials and Methods
Cell lines & culture
Human embryonic kidney (HEK2931) (ATCCte CRL-1573'"}. murine alveolar
macrophage (MH-S) (ATCC® CRL-2019"'), and murine fibroblast (3T6) (ATCC® CCL-96'"}
cells were obtained from the American Type Culture Collection {ATCC). All cells were
maintained at 5% CO2 and 37°C. MH-S cells are Simian Virus 40 {SV-40) transformed
alveolar macrophages isolated from the bronchoalveolar lavage of BALB/c mice and are
used to study alveolar macrophages and their role in lung pathologies (Mbawuike and
Herscowitz, 1 989).
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HEK293T cells were maintained in Dulbecco's Modified Eagle's Medium ( DMEM)
supplemented with 1 0% heat-inactivated fetal bovine serum (HIFBS), 4 mM L-glutamine, 1
mM pyruvate and 3.7 g/1 sodium bicarbonate. In the initial plating of HEK293T, media was
supplemented with 100 IU/mL penicillin and 100 µg/mL streptomycin. MH-S cells were
maintained in Roswell Park Memorial Institute (RPMI) media supplemented with 1 0%
HIFBS, 2 mM L-glutamine, 1 mM pyruvate, 1.5 g/1 sodium bicarbonate, I O mM HEPES
buffer, l 4.3mM 2-mercaptoethanol. 3T6 cells were maintained in DMEM supplemented with
10% HIFBS, 4 mM L-glutamine, I mM pyruvate and 3.7 g/1 sodium bicarbonate. Media pH
was adjusted to 7.2 using

1 N HCI prior to sterilization by filtration using a 0.22 µm filter.

Plasmid Preparation
Plasmids necessary for transfection were prepared by either phenol-chloroform
extraction or PureYield® (Promega, A l 223) plasmid extraction. The manufacturer's protocol
was used to prepare plasmids using PureYield®. Phenol-chloroform extraction was
performed according the alkaline lysis method described by Addgene (Addgene, 2016).
Glycerol stocks containing competent E. coli cells expressing the following plasmids were
used to inoculate Luria broth media containing 1 OOµg/ml Ampicillin: CD40 shRNA pLK0.1
plasmid (clone ID: TRCN0000066244, clone name: NM_Ol 1 61 l . l -672sl c l ; Sigma-Aldrich,
St Louis, MO, USA), pMD2.G (Addgene, #1 2259), and pAdTrack (Addgene, #16404).
Cultures were shaken at 300rpm for 1 8 hours at 37°C. Extracted plasmids were resuspended
in Tris EDTA buffer. DNA concentration was determined using a NanoDrop™
spectrophotometer. Plasmid maps for pLKO. l , psPAX2, and pMD2.G are shown in the
appendix.
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GFP Transfection
HEK293T cells were transfected with 8 µg of pAdTrack using L ipofectamine 2000®.
Lipofectamine transfection was conducted per manufacturer's protocol (Therrnofisher, 2013).
Green Fluorescence Protein (GFP) expression was analyzed by fluorescence microscopy 48
hours post transfection. Cells were counted and the percentage of cells expressing GFP was
used as a measure of transfection efficiency. Cells were counted under 200X magnification
using fluorescence microscopy on an Olympus IMT-2. The average of the percent GFP
expression was averaged for 2 fields chosen at random. Wild type HEK293T cells served as
a negative control, and the positive control was AdTrack GFP that was isolated by
PureYield® extraction by Dr. Brittany Albaugh (EMU), and has been used successfully in
the past.

Lentiviral Production
Lentiviral particles were produced by an adapted protocol provided by the plasmid
repository Addgene (Addgene, 2016). HEK293T cells were plated in 60 mm plates to obtain
approximately 60% confluency at time of transfection. Media was replaced with DMEM,
without serum or antibiotics, 2 hours prior to transfection.
To produce the lentivirus, HEK293T cells were transfected using Lipofectamine
2000®. The transfection inoculum contained 4 µg of CD40 shRNA pLKO.l plasmid, 3 µg of
psPAX2, and 1 µg of pMD2.G. Media for cultures was replaced with DMEM without
antibiotics 24 hours post transfection. At 48 and 72 hours post transfection, culture
supernatant was harvested and stored at 4°C. The supernatant, containing lentiviral particles,
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was centrifuged for

5 minutes at 500 x g / 4°C, filtered through a 0.22 µm filter and stored at

-70° C until use. A summary of lentiviral production is shown in figure 6.

Leiltlvfral Particles

Step 1. Tr.msfectlon of Plasmlds

·Step 2. Removal of
Plasmlds/Replacement
of Media

Step 3. Harvest Media
Containing lentlviral
Partkles

Step 4. Centrifuge Media
and Store Lentfvlral
Particles at-80"C

Figure 6. Summary of Lentiviral Production.

Generation ofCD40 Silenced MH-S Cell Lines
MH-S cells were plated in 60mm plates to obtain approximately 60% confluent flasks
at the time of transduction. NPB {1-5) refers to CD40 silenced lines that showed the greatest
CD40 suppression. NPB1 and 2 were the earliest transductions using lentivirus produced by
plasmids isolated by phenol-chloroform extraction. NPB3, 4 and 5 were transductions using
lentivirus produced by plasmids isolated by PureYield® extraction. Twenty-four hours after
plating, the media was replaced with fresh media and 1 ml of media containing lentiviral
particles was added to each plate. After 24 hours of incubation, the media was replaced with
fresh media containing 4 µg/ml puromycin {Sigma Aldrich, P8833) to select for cells
containing the CD40 shRNA insert. To assess the effectiveness of puromycin selection, wild
type MH-S cells were also grown in media containing 4 µg/ml puromycin and media was
replaced every 3 days. Cytotoxicity in non-transduced cells was analyzed 5 days post
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transduction to ensure that adequate selection pressure was present due to puromycin. A
summary of lentiviral infection is shown in figure 7.
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With leiltlvlrus

Step 2. Incubated for
24 hours

...

E,.,,.J �
T.-c.19

Step 3. Selected For' Cells
Containing L�ntMral Insert
Wit� 4µg/ml Puromycfn

Figure 7. Summary of Lentiviral Mediated CD40 Silencing.

CD40 Stability ofSilencing
The stability of CD40 silencing was assessed to determine if the removal of
puromycin caused CD40 silenced cells to revert to the wild type phenotype. NPB3 was
grown in separate flasks, in media with and without 4 µg/ml puromycin for 11 days. Media
was replaced every 2-3 days during incubation period. Cells were analyzed for CD40 surface
expression 1 1 days after separation using the flow cytometric parameters described in the
section below.

Flow Cytometric Analysis
Cultured cells were detached from flasks with 5 mL of Accutase (eBioscience, 004555-56} and suspended in FACS staining buffer (PBS, 1% bovine serum albumin, 0.1%
sodium azide} to obtain a concentration of 107cells per mL. One-hundred microliters of cell
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solution was used for each reaction, and 1 µI of the following antibodies was added to each
reaction to obtain a final antibody concentration of2µg/ml: anti- mouse CD40 Allophycocyanin (APC) conjugate (eBioscience, 1 7-0402-80), and anti-mouse CD86 (phycoerythrin) PE/Cy7) (eBioscience, 1 2-5322-8 1). Rat lg2aic (eBioscience, 25-4321 -81)
was used as an isotype control for CD86 staining. Cells were stained on ice for 1 hour in the
dark, rinsed with PBS, and fixed with 2% paraformaldehyde in PBS. We used a BO
FacsCalibur flow cytometer and analyzed the data we obtained using CellQuest software.
The instrument was set up to collect 10,000 of all events for each run. An analysis gate was
set to represent 90% of all events based on forward and side scatter. The following
instrument settings were used:

Table 1 . Flow Cytometry Parameters. {Threshold: FSC Value: 52)
Parameter
Pl
P2
P3
P4
PS
P6
P7

Detector
FSC
SSC
FLl
FL2
FL3
FL2-A
FL4

Voltage
E-1
380
500
381
650
NIA
675

Amp Gain
5.41
1 .00
1 .50
1 .00
1 .00
l .00
1 .00

Mode
Lin
Lin
Lin
Log
Log
Lin
Log

MA V-1 Infection
MH-S wild type cells and a silenced strain, NPB5, were grown to approximately 80%
confluence prior to infection. NPB5 cells were used in this experiment because it is the
CD40-silenced line that showed the greatest reduction in CD40 expression. Cells were
infected with 2 mL of a 1 :10 dilution ofMAV-1 viral stock and incubated for l hr. Based on
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the molecular weight of the MAV-1 genome and the DNA concentration of the viral stock,
there are approximately 10 10 viral genomes per mL of viral stock. Based on this
concentration, and the assumption that each T75 flask contained approximately I0 7 MH-S
cells at the time of the infection, the experimental multiplicity of infection (MOI) is
approximately 2000. RT-qPCR analysis of the viral stock demonstrated a detection limit for
MAV-1 of approximately 100 viral genomes (data not shown). Thus, the true MOI is more
likely between 20-2000. However, because we were unable to plate the virus to determine an
actual viral titer, this calculation ofMOI is an estimation. The original MAV-1 stock used to
produce the virus was obtained from ATCC (VR-550™) and working stocks were generated
from previous infections in 3T6 cells.
Each flask was tilted every 15 minutes to prevent desiccation of cells during
infection. After infection, cells were refed with 15mL of RPMI with 2% HIFBS. The media
containing virus was not removed prior to refeeding cells. The cultures were incubated at
3rC until their respective analysis times.
At 24 hours pre and post infection, cells were detached with 5 mL of Accutase and
washed with 10 mL of PBS per T75 flask. Cells were analyzed for the expression of CD40
and CD86 using flow cytometry.
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Results

Lentiviral Plasmid Transfection Verification by GFP
Lipofectamine 2000® transfection efficiency was analyzed to compare the quality of
plasmids produced by phenol-chloroform extraction and PureYield® extraction. We isolated
GFP plasmid from logarithmically growing £. coli cells using phenol-chloroform and
PureYield® extraction, and transfected these plasmids into HEK.293 cells. Untransfected
HEK.293 cells served as a negative control to examine the contribution of background
fluorescence. We compared these methods of plasmid extraction to optimize the production
of lentivirus.
Transfection with GFP-expression plasmid isolated by phenol-chloroform extraction
resulted in poor expression and fluorescence (3%) relative to the positive control (44%) and
PureYield® GFP (53%) (Figure 7) (Table 2). No fluorescence was observed in the negative
control. These results show that GFP plasmids isolated by PureYield® extraction results in
more efficient GFP expression than using the same plasmid isolated by phenol-chloroform
extraction.
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Figure 7. Fluorescence-microscopy analysis of GFP transfection efficiency in HEK293T
cells. (Olympus IMT-2, 200X magnification)

Table 2. Percentage HEK293T cells expressing GFP.
Sample

Transfection Efficiency

Negative Control

0%

Positive Control

44%

Phenol-Chloroform GFP

3%

PureYield® GFP

53%

Validation ofCD40 Silencing
Flow cytometry was used to visualize CD40 protein surface expression and verify
successful silencing oftransduced lines. We used the mean fluorescence intensity (MFI) to
represent the level of CD40 surface expression of the population. The average MFI of
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unstained cells was subtracted to correct for background fluorescence. We observed
decreased CD40 expression in 5 transfected lines (hence denoted as NPB1-NPB5). Cells
were cultured in media containing 4µg/ml puromycin and analyzed by flow cytometry
between 4 and 15 days post lentiviral (shRNA) transfection. Relative expression is based on
basal expression of CD40 in wild type MH-S cells. However, the silenced cell lines
transduced with lentivirus produced by PureYield® plasmids showed dramatically lower
CD40 expression compared to cell lines generated from lentivirus produced with plasmid
DNA isolated by phenol-chloroform extraction. Lower silencing efficiency suggests that
plasmids isolated by phenol-chloroform extraction result in poor lentiviral yield. A summary
of CD40 expression in silenced lines is shown in Figure 8. Among the cell lines generated,
NPB5 showed the greatest reduction in CD40 expression and was used for our infection
assay.
80%
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Figure 8. CD40 Expression in Silenced Lines: A Comparison of Plasmid Preparation
Methods.
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Stability ofCD40 Silencing
We examined if the absence of puromycin affects the stability of CD40 silencing.
NPB3 cells were grown in media with and without puromycin, and were analyzed by flow
cytometry 11 days (4 passages} of cell culture. CD40 expression was slightly upregulated in
the cells that had been grown without puromycin (Figure 9). The observed shift represents an
approximately 2-fold increase in CD40 expression.

g ________________________________
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Figure 9. Stability of CD40 silencing. NPB3 cells were grown with (green} and without
puromycin (pink} for 11 days and analyzed by flow cytometry. The results show that the
removal of puromycin caused an increase in CD40 expression.

CD40/CD86 Expression During MA V-1 Infection
We analyzed surface expression of CD40 and CD86 to determine how MAV-1
infection alters the expression of costimulatory molecules on MH-S cells. Flow cytometry
was used to analyze surface expression of CD40 and CD86 24 hours prior to, and 24 hours
following, infection with MAV-1. CD86 is another immunological marker found on antigen
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presenting cells. CD86 expression was analyzed to verify that silencing of CD40 was
specific, and did not alter the expression of other cell surface proteins. The MFI of unstained
cells was subtracted to correct for background fluorescence when analyzing CD40, and the
MFI of cells stained with a PE/Cy7 isotype control was subtracted to correct for background
fluorescence when analyzing CD86 expression. We observed a slight decrease in CD86
expression in NPB5 uninfected and infected cell lines, when compared to wild type MH-S
expression under similar conditions.
Flow cytometric analysis revealed CD40 surface expression was upregulated in both
the silenced and control cultures following infection with MAV-1. Wild-type MH-S cells
showed an approximately 5-fold increase in CD40 surface expression, while NPB5 cells
showed a 16-fold increase in CD40 expression. Although elevated relative to basal
expression, CD40-levels in infected NPB5 cells were approximately 55% lower relative to
CD40 expression in infected MH-S cells. Flow cytograms for CD40 and CD86 are shown in
figures 10 and 11. CD40 expression and CD86 expression are also represented in figures 12
and 13. These results confirm that CD40 is upregulated in silenced and wild type MH-S cells
by approximately I I-fold and 5-fold, respectively. CD86 is upregulated following infection
by MAV-I by approximately 70% in both cell lines. These results show that CD40 silencing
was specific because silencing did not dramatically alter the expression of CD86.
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Figure 10. Representative flow cytograms of CD40 expression in MH-S (a) and NPB5(b)
cells in response to MAV-1 infection. CD40 expression is reduced in NPBS cells when
compared to MH-S control cells. CD40 surface expression is upregulated in MH-S and NPBS
lines following infection with MAV-1 .
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Discussion

Lentiviral Plasmid Transfection Verification by GFP
We compared the transfection efficiency of a GFP-expression plasmid to examine
how the method of DNA preparation alters DNA uptake and expression in HEK293T cells.
The initial lentiviral transductions (NPB 1 & NPB2) were conducted using lentivirus
generated from plasmids extracted by phenol-chloroform extraction and showed poorCD40
suppression. We hypothesized that plasmids extracted by phenol-chloroform extraction may
not be efficiently expressed in HEK293 cells. Poor plasmid transduction would result in poor
Jentivirus production and lower lentiviral titer, resulting in reduced the probability of
successful shRNA integration andCD40 silencing. Optimizing plasmid transfection
efficiency improved lentiviral production and the subsequent silencing ofCD40 of MH-S
cells. We compared AdTrack GFP plasmids that were isolated from phenol-chloroform and
PureYield® extractions.
Plasmid extraction by PureYield® led to more successful transfection of the GFP
plasmid, as assessed by fluorescence microscopy. No fluorescence was observed in the non
transfected control samples, suggesting that the background fluorescence in HEK293T cells
is negligible in our analysis.Cells that were transfected with GFP-plasmid isolated by
phenol-chloroform showed very low transfection efficiencies. Poor GFP-plasmid transfection
suggests that lentiviral production will also be poor using this method. Flow cytometry data
supports thatCD40 is suppressed to a greater level in cells that were transduced with
lentivirus produced by plasmids isolated by PureYield® extraction. The transfection
efficiency was comparable between the positive control (produced in another laboratory) and
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our PureYield® extracted GFP plasmid, which is to be expected given that both plasmids
were obtained using the same extraction method.
The low level of expression in phenol-chloroform extracted GFP suggests that
plasmids isolated by phenol-chloroform extraction are not suitable for expression in
HEK293T cells. Phenol-chloroform extraction may have carried some endotoxin from the
bacterial culture. This could alter the efficiency of HEK293T cells to take up exogenous
DNA. PureYield® extraction kits are specifically designed to neutralize endotoxin
contamination, which may explain the differences in expression between the two methods. It
also is possible that phenol and/or chloroform may have been carried over during plasmid
preparation, which would have been toxic to the cells. These data suggests that lentivirus
production by plasmids that were extracted by phenol-chloroform will be Jess efficient, result
in lower viral titers in harvested media, and be Jess efficient at silencingCD40.

Generation o/CD40 Deficient MH-S cells
FiveCD40 silenced lines were generated from lentivirus produced by plasmids
extracted by phenol chloroform extraction (NPB 1-2) and PureYield extraction (NPB3-5).
Lines NPB 1-2 showed 26-28% reduction in cell surface expression ofCD40 compared to
wild type controls. Lines NPB3-5 showed a 56-79% reduction in cell surface expression of
CD40 compared to wild type controls. Multiple factors can influence the degree of
suppression such as plasmid purification method, puromycin concentration and culture
conditions. These results support our GFP assay, which suggests that lentiviral production
plasmids extracted by PureYield® result in a higher transfection efficiency than plasmids
extracted by phenol-chloroform extraction.
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Stability ofSilencing in the Absence ofPuromycin
We comparedCD40 expression in cells that had been maintained in media with and
without puromycin. Stable expression of the silencing construct is essential because
subsequent MAV-1 infection studies would be conducted in the absence of puromycin. In
addition, because puromycin is a protein synthesis inhibitor, we wanted to ensure that any
effects we observe in theCD40 silenced cells are due the silencing construct and not
interactions with puromycin.
Our results showed that the effect ofCD40 silencing is slightly reduced in cells that
were grown without puromycin for 11 days. This increase in expression suggests that the
removal of puromycin as a selection pressure, results in drift towards wild typeCD40
expression levels. The MAV-1 infection in this experiment used cells that were grown
without puromycin for only 2 days, so it is unlikely that the same level drift would be
observed in our cells.

CD40/CD86 Expression Following MA V-1 Infection
Flow cytometric analysis shows that CD40 surface expression is increased in silenced
and unsilenced cell lines following infection with MAV-1, supporting previous experiments
that have shown an approximately 4-fold increase inCD40 expression following infection
with MAV-1. We analyzedCD86 as a marker to determine if CD40 silencing was specific
and did not impact the expression of other antigens. MH-S cells showed approximately 5fold greater expression ofCD40 following infection with MAV-1. Uninfected NPB5 cells
showed approximately 80% reduction inCD40 relative to wild type MH-S cells. NPB5
showed an approximately 15-fold increase inCD40 compared to uninfected NPB5 cells. This
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dramatic increase in expression is largely due to the low level of CD40 expression observed
in silenced cells. Infected NPB5 cells expressed almost 3 times as much CD40 as uninfected
MH-S cells. and half as much CD40 as infected MH-S cells.
We did not account for the dramatic CD40 upregulation occurring to the extent that it
did in the CD40 silenced lines. An ideal silencing construct would maintain effective
silencing even after infection with MAV-1. However, infected CD40 silenced lines still
showed a 2-fold reduction in CD40 expression compared to wild type infected cells. A 2-fold
difference may still be large enough to reveal the role of CD40 up regulation following
MAV-1 infection.
It was hypothesized that CD86 would be unaffected by CD40 silencing. The data
suggest that CD40 silenced lines showed a slight reduction in CD86. Infection with MAV-1
caused an increase in CD86 expression in silenced and unsilenced cell Jines. Both cell lines
showed approximately the same relative upregulation (+66%).
These results are consistent with the hypothesis that CD40 and CD86 are upregulated
in MAV-1 infected cells to promote macrophage activation and antigen presentation. CD40
has been shown to be upregulated as early as 9 hours post infection (Angell, M.G. personal
communication). Previous RT-qPCR data has also shown that MAV-1 early genes are
expressed during this timeframe (Angell, M.G, personal communication). Given that CD40
coincides with the period of MAV-1 early gene expression, it is likely, but not proven, that
MAV-1 upregulation is the result of pattern recognition receptors responding to MAV-1
infection by upregulating CD40 and other costimulatory markers to promote activation of
naive T-cells. Similarly, HIV-I Tat protein has been shown to cause an upregulation in
CD40, CD80 and CD86 in monocyte derived dendritic cells, and promote macrophage
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maturation, antigen presentation, and a T-helper I response {Fanales-Belasio et al., 2002).
Although Tat has its own effector functions in viral replication, it is also a potential target for
PRRs {Mogensen et al., 2010). These observations support the hypothesis that CD40 and
CD86 upregulation are the result of macrophage activation. However, it is still unclear as to
whether MAV-1 can benefit from this upregulation.
It has been shown that adenoviruses can activate their own transcription in response
to some inflammatory cytokines induced by CD40 signaling (Komer et al., 1992). Through
this mechanism, MAV-1 would be able to exploit host inflammatory cytokines to promote its
own pathogenesis. This prompts inquiry into the true function of CD40 signaling.
Classically, it would be assumed that this upregulation of CD40 is the result of macrophage
activation and functions to activate other aspects of the immune system. While this may be
partially true, it also possible that CD40 upregulation promotes MAV-1 replication.

Future Directions
We did not anticipate that MAV-1 infection would reduce the effects of our silencing
construct. Manufacturers commonly market silencing constructs that that boast 80%
silencing efficiencies. Thus, the ideal silencing method would maintain silencing near this
level, even after infection with MAV-1. Potential methods of increasing the silencing
efficiency include using multiple CD40 shRNA transcripts in a silencing cocktail, or using a
CRISPR system, that could be used to inactivate the CD40 (Cong et al., 2013). It is likely
that the latter method will be more effective due to the CRISPR system modifying the CD40
DNA within the genome. In comparison, shRNA mediated silencing leaves the CD40 gene
intact, while degrading the CD40 mRNA transcripts.
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However, MAV-1 infected CD40 silenced MH-S cells still maintained a 2-fold
reduction in CD40 expression compared to wild type, and may be a valuable tool to study the
role of CD40 upregulation in vitro. Studies have shown that a 2-fold difference in CD40
expression on myeloid derived suppressor cells is sufficient to dramatically alter gene
expression (Ding et al., 2015). Therefore, the silenced cells generated in this study may still
be used to further elucidate the role of CD40 signaling in macrophage cells by conducting a
similar experiment with the addition of CD40 ligand to activate CD40 signaling. This would
provide a clearer description of the role of CD40 in vivo, where other costimulatory antigens
would be present to activate these pathways (Stout and Suttles, 2004).
In a broader sense, there are many other perspectives to examine the function of
CD40 upregulation following MAV-1 infection. One could observe CD40 expression in
MAV-1 BALB/c and C57BU6 alveolar macrophages. If CD40 upregulation is the result of
an immunological process found in BALB/c mice, but not C57BU6, we would expect to see
an increase in CD40 expression in BALB/c macrophages, but not C57BU6 macrophages.

C57BU6 derived alveolar macrophages are available from the ATCC (ATCC, 2017).
However, the use of immortalized cell lines creates special limitations when studying
adenoviral replication. MH-S cells are derived from BALB/c derived macrophages, but are
altered due to immortalization with SV-40. To reduce the number of confounding variables,
an ideal experiment would be conducted using mice, since this would provide the most
accurate depiction of MAV-1 infection in mice.
In conclusion, further characterization of the CD40 silenced cell lines generated in
this study may reveal the role of CD40 upregulation following MAV-1 infection. However,
the cell lines we generated may not provide optimal CD40 silencing during MAV-1
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infection. It may be worthwhile to generate a newCD40 silenced cell line using a silencing
construct that maintains CD40 suppression following MAV-1 infection. The results of this
study support previous experiments that have shown a 5-fold increase in CD40 expression is
observed following infection with MAV-1. In addition, we observed a slight increase in
CD86 following infection with MAV-1 . Future studies could further characterizeCD40
silenced MH-S cells to understand the role ofCD40 andCD86 upregulation following
infection with MAV-1 .
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